Bone mineral disorders
Bone and mineral concerns are common alongside long-term diabetes and chronic kidney disease — and, importantly, type 2 diabetes can raise fracture risk even when a bone density scan looks normal. That's why bone health is assessed as part of long-term metabolic care, not only after a fracture happens.
Your bone health assessment pathway
Reviewing Your Risk Factors
Diabetes duration and control, kidney function, thyroid status, age, menopause, and any prior fractures.
Blood Tests
Calcium, phosphate, parathyroid hormone (PTH), vitamin D, and related markers.
Bone Density Scanning (DEXA)
Where indicated, to measure bone mineral density, coordinated through partner imaging facilities.
Fracture Risk Assessment
Combining your bone density result with clinical risk factors — since density alone can under-represent risk in diabetes.
A Personalized Plan and Follow-Up
Addressing the underlying cause alongside general bone health measures, reviewed over time.
Symptoms
- Often no symptoms until a fracture occurs
- Bone pain, in some underlying conditions
Causes & risk factors
- Long-duration diabetes
- Chronic kidney disease, which affects mineral and bone metabolism
- Thyroid or other endocrine conditions
- Age and, for women, menopause
Vitamin D deficiency is very common in India — studies report roughly 70–90% prevalence in adult women. A systematic review of over 31,000 Indian adults found osteoporosis in 18.3% overall, rising to 37% at age 60 and older, with an estimated 50 million people in India affected by osteoporosis or low bone mass.
Why bone health matters in metabolic care
Bone and mineral health connects to several conditions this practice already manages, which is why it's assessed alongside them rather than as a separate concern.
Kidney disease
Chronic kidney disease disrupts calcium, phosphate, and vitamin D metabolism — a pattern known as CKD-MBD
Diabetes and age
Both diabetes and age affect fracture risk, sometimes independently of what a bone density scan shows
Thyroid balance
Thyroid hormone imbalance, including over-replacement of thyroid medicine, can affect bone turnover
Types of bone and mineral concerns we assess
"Bone mineral disorders" covers more than one condition — the underlying cause shapes the assessment and the treatment plan.
| Category | What it is | Who's typically affected |
|---|---|---|
| CKD-MBD | A mineral and bone disorder caused by chronic kidney disease affecting calcium, phosphate, PTH, and vitamin D metabolism | Patients with chronic kidney disease, including diabetic kidney disease |
| Osteoporosis | Reduced bone density and strength that increases fracture risk | Common with age, and more common after menopause |
| Diabetes-related bone fragility | Increased fracture risk from changes in bone quality, sometimes without reduced bone density | Patients with longer-duration or poorly controlled diabetes |
| Thyroid-related bone loss | Bone loss driven by excess thyroid hormone, whether from thyroid disease or over-replacement | Patients with hyperthyroidism or thyroid medicine doses that run higher than needed |
The diabetes bone paradox
This is worth understanding directly, because it changes how bone health is assessed in diabetes rather than being a minor footnote.
Why a normal bone scan doesn't rule out higher fracture risk
- In type 2 diabetes, bone density on a scan can look normal, or even higher than average, while fracture risk is still meaningfully increased — research puts the relative risk of hip fracture at roughly 1.7 times that of people without diabetes
- This happens because diabetes affects bone quality, not just bone density — a dimension standard bone density scanning doesn't fully capture
- Glycemic control matters directly for bone: research associates each 1-point rise in HbA1c with roughly an 8% increase in fracture risk, and sustained poor control (HbA1c above 9% over 2 years) with a 29% higher fracture risk
- This is one more reason consistent glucose management is part of protecting your bones, not only your other organs
Understanding your bone density result
If you have a DEXA scan, your result is reported as a T-score, compared against the classification below.
- In diabetes, your T-score is interpreted alongside your other risk factors, not in isolation — see "the diabetes bone paradox" above
| T-score range | Category | What it generally means |
|---|---|---|
| −1.0 or higher | Normal bone density | No evidence of low bone mass on this scan |
| −1.0 to −2.5 | Osteopenia (low bone mass) | Bone density is lower than normal, worth monitoring and addressing risk factors |
| −2.5 or lower | Osteoporosis | Bone density is significantly reduced, and treatment is often considered |
When bone-strengthening treatment may be considered
Current ADA guidance sets out specific situations where treatment is typically discussed, rather than leaving this to a general impression of risk. This informs a conversation with your care team — it isn't a self-diagnosis checklist.
- A T-score of −2.5 or lower
- A history of a fragility fracture (a fracture from a minor fall or everyday activity)
- A FRAX fracture-risk score of 3% or higher for hip fracture, or 20% or higher for major osteoporotic fracture
- A T-score between −2.0 and −2.5 alongside additional risk factors for fracture
How it’s diagnosed
Assessment includes blood tests for calcium, phosphate, and related markers, and bone density scanning (DEXA) where indicated, coordinated through partner imaging facilities.
How it’s treated
Treatment addresses the underlying cause alongside general bone health measures (calcium and vitamin D status, weight-bearing activity), individualized to the specific mineral or bone finding.
When to seek care
- A fracture from a minor fall or low-impact injury
- New, unexplained bone pain
- A noticeable loss of height or a new stooped posture
- New, severe back pain, especially after bending or lifting
FAQ
What are bone mineral disorders?
This covers a group of conditions affecting bone density, bone quality, or mineral metabolism (calcium, phosphate, vitamin D, and related hormones) — including CKD-MBD, osteoporosis, diabetes-related bone fragility, and thyroid-related bone loss.
Why would diabetes affect bone health?
Long-term diabetes and related kidney changes can affect bone density and mineral metabolism over time, which is why bone health is sometimes assessed as part of long-term diabetes care.
What is the "diabetes bone paradox"?
It's the finding that type 2 diabetes is linked to normal or even higher bone density, yet still a higher fracture risk — roughly 1.7 times for hip fracture — because diabetes affects bone quality in ways a density scan doesn't fully capture.
Why would my bone scan look normal if my fracture risk is high?
Because bone density and bone quality aren't the same thing. In diabetes, bone quality can be affected independently of density, which is why your bone scan result is interpreted alongside your other risk factors rather than alone.
What is CKD-MBD, and how is it different from osteoporosis?
CKD-MBD is a mineral and bone disorder caused specifically by chronic kidney disease, affecting calcium, phosphate, parathyroid hormone, and vitamin D metabolism. Osteoporosis is reduced bone density and strength, most often related to age or menopause. The two can coexist but are assessed and managed somewhat differently.
How is bone health assessed?
Through a review of your risk factors, blood tests (calcium, phosphate, PTH, vitamin D), and bone density scanning (DEXA) where indicated — combined into a fracture risk assessment rather than any single test alone.
What do T-scores mean?
A T-score of −1.0 or higher is considered normal bone density; −1.0 to −2.5 is osteopenia (low bone mass); −2.5 or lower is osteoporosis. In diabetes, this is interpreted alongside other risk factors, not in isolation.
When is bone-strengthening treatment considered?
Current guidance points to a T-score of −2.5 or lower, a history of a fragility fracture, a FRAX score of 3% or higher for hip fracture (or 20% or higher for major osteoporotic fracture), or a borderline T-score with additional risk factors — discussed individually with your care team.
Does good blood sugar control protect my bones?
Yes — research associates each 1-point rise in HbA1c with roughly an 8% increase in fracture risk, and sustained poor control with a substantially higher fracture risk. Consistent glucose management is one part of protecting bone health.
How common is vitamin D deficiency in India?
Very common — studies report roughly 70–90% prevalence in adult women, and osteoporosis affects an estimated 50 million people in India overall.
Does thyroid disease affect bones?
Yes — excess thyroid hormone, whether from thyroid disease itself or from a thyroid medicine dose that runs higher than needed, can contribute to bone loss over time.
Can bone loss be treated?
Often, yes — treatment addresses the underlying cause (such as kidney disease, thyroid imbalance, or vitamin D deficiency) alongside general bone health measures, individualized to your specific findings.
How often should bone health be screened?
This depends on your individual risk factors — diabetes duration and control, kidney function, age, and prior results — rather than a fixed schedule for everyone. Your care team will advise on timing suited to you.
Sources
- ADA Standards of Care 2026: Older Adults
- KDIGO 2017 Clinical Practice Guideline Update for CKD-MBD
- Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility
- A Multidisciplinary Approach to Addressing Barriers in Osteoporosis Screening, Diagnosis, Therapy Sequencing, and Adherence in India
Medical disclaimer: Content on this page is for general education and is not a substitute for individualized medical advice, diagnosis, or treatment. Outcomes vary between patients. Boston Diabetes Center is outpatient / day-care specialty centre with an on-site diagnostic lab and pharmacy — no inpatient beds; imaging and inpatient care are coordinated through partner facilities.